NEW YORK CITY, NY / ACCESS Newswire / November 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Prelude Therapeutics Incorporated ("Prelude" or the "Company") (NASDAQ:PRLD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Prelude and certain of its officers and/or […]

NEW YORK CITY, NY / ACCESS Newswire / November 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Alector, Inc. ("Alector" or the "Company") (NASDAQ:ALEC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Alector and certain of its officers and/or directors

ZAGREB, Croatia, Nov. 16, 2025 (GLOBE NEWSWIRE) — UPAD, the progressive, fintech-driven ticketing infrastructure startup, has deployed “Rakija Pit”, a culturally-coded anti-automation signal created to identify and quarantine bots during high-demand ticket launches. Rakija Gate was activated for the first time ever during the New Year's Eve sale for the biggest young regional singer Aleksandra

UPAD Launches “Rakija Gate” – The First Balkan Anti-Bot Protocol – During the Most Attacked Concert On-Sale in Regional History The fast-growing ticketing infrastructure startup activated its cultural-tech anomaly filter for the first time during Aleksandra Prijović's New Year's on-sale, organised by Extra FM – a launch overwhelmed by automated traffic. GlobeNewswire November 16, 2025

NEW YORK CITY, NY / ACCESS Newswire / November 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Vera Bradley, Inc. ("Vera Bradley" or the "Company") (NASDAQ:VRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Vera Bradley and certain of its

NEW YORK CITY, NY / ACCESS Newswire / November 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Alkami Technology, Inc. ("Alkami" or the "Company") (NASDAQ:ALKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Alkami and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / November 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Alaska Air Group, Inc. ("Alaska Air" or the "Company") (NYSE:ALK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Alaska Air and certain of

NEW YORK CITY, NY / ACCESS Newswire / November 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Akebia Therapeutics, Inc. ("Akebia" or the "Company") (NASDAQ:AKBA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Akebia and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / November 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Alvotech ("Alvotech" or the "Company") (NASDAQ:ALVO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Alvotech and certain of its officers and/or directors have

NEW YORK CITY, NY / ACCESS Newswire / November 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of VirTra, Inc. ("VirTra" or the "Company") (NASDAQ:VTSI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether VirTra and certain of its officers and/or directors